Trial Profile
A trial to study bevacizumab effectiveness and primary tumor location in metastatic colorectal cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 04 Apr 2016 New trial record